LILRB2 Antibody

Artikelnummer: ASB-OACD05261
Artikelname: LILRB2 Antibody
Artikelnummer: ASB-OACD05261
Hersteller Artikelnummer: OACD05261
Alternativnummer: ASB-OACD05261-100UL,ASB-OACD05261-1ML
Hersteller: Aviva
Wirt: Rabbit
Kategorie: Proteine/Peptide
Applikation: ICC, IHC, IP, WB
Spezies Reaktivität: Human, Mouse
Immunogen: Range: Leu53 - Val255
Alternative Synonym: CD85 antigen-like family member D,CD85D,Ig-like transcript 4,ILT4,ILT-4,Immunoglobulin-like transcript 4,leucocyte Ig-like receptor B2,leukocyte immunoglobulin-like receptor subfamily B member 2,leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2,LIR2,LIR-2,MIR10,MIR-10,monocyte/macrophage immunoglobulin-like receptor 10,myeloid inhibitory receptor 10.
Receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles (PubMed:11169396, PubMed:12853576, PubMed:16455647, PubMed:20448110, PubMed:27859042). Involved in the down-regulation of the immune response and the development of tolerance. Recognizes HLA-G in complex with B2M/beta-2 microglobulin and a nonamer self-peptide (peptide-bound HLA-G-B2M) triggering differentiation of type 1 regulatory T cells and myeloid-derived suppressor cells, both of which actively maintain maternal-fetal tolerance (PubMed:20448110, PubMed:27859042, PubMed:16455647). Competes with CD8A for binding to class I MHC antigens. Inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions (PubMed:11875462, PubMed:12853576, PubMed:9548455, PubMed:9842885).
Klonalität: Polyclonal
Konzentration: 0.5 mg/ml
Molekulargewicht: 52 kDa
NCBI: 10288
Formulierung: Liquid. PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
DAB staining on formalin fixed paraffin-embedded Liver Cancer Tissue.
DAB staining on formalin fixed paraffin-embedded Pancreas Cancer Tissue.
Western Blot with Human Recombinant LILRB2